Composition
- Active ingredients
- PLERIXAFOR 24MG/1.2ML (20MG/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- PLERIXAFOR 24MG/1.2ML (20MG/ML) · SolutionANDA215334-001 · Prescription
- PLERIXAFOR 24MG/1.2ML (20MG/ML) · SolutionANDA215698-001 · Prescription
- PLERIXAFOR 24MG/1.2ML (20MG/ML) · SolutionANDA205197-001 · Discontinued
- PLERIXAFOR 24MG/1.2ML (20MG/ML) · SolutionANDA206644-001 · Prescription
- PLERIXAFOR 24MG/1.2ML (20MG/ML) · SolutionANDA205182-001 · Prescription
- PLERIXAFOR 24MG/1.2ML (20MG/ML) · SolutionANDA213672-001 · Prescription
- PLERIXAFOR 24MG/1.2ML (20MG/ML) · SolutionANDA208980-001 · Discontinued
- PLERIXAFOR 24MG/1.2ML (20MG/ML) · SolutionThis page
- PLERIXAFOR 24MG/1.2ML (20MG/ML) · SolutionANDA211901-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA217560.
At a glance
- Brand name
- Plerixafor
- Route
- Subcutaneous
- Dosage form
- Solution
- Applicant
- Hetero Labs LTD Vi
- Status
- Prescription
- FDA approval
- 16 Jun 2025
- Application
- ANDA217560-001